SCHEMBL30830739

SCHEMBL30830739

CC(C)(C)OC(=O)N1CCC2(CC1)CCN(c1ccc(-c3ccc(OCc4ccccc4)nc3OCc3ccccc3)cc1F)CC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.42
TNKS O95271 2/20 0.42
TNKS2 Q9H2K2 2/20 0.42
TACR1 P25103 1/20 0.41
CYP11B2 P19099 1/20 0.41
PRMT5 O14744 4/20 0.40
CCNT1 O60563 1/20 0.40
CCNA2 P20248 1/20 0.40
CDK2 P24941 1/20 0.40
CDK9 P50750 1/20 0.40
CCNA1 P78396 1/20 0.40
TLR9 Q9NR96 2/20 0.40
TLR7 Q9NYK1 2/20 0.40
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39
GPR119 Q8TDV5 3/20 0.39
ACHE P22303 1/20 0.38
ALOX5AP P20292 1/20 0.38
FEN1 P39748 1/20 0.38
KIT P10721 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25940751 0.95 PARP1 (0.43) PARP1TNKSTNKS2TACR1CYP11B2
SCHEMBL30136015 0.95 PARP1 (0.43) PARP1TNKSTNKS2TACR1CYP11B2
SCHEMBL31018307 0.95 CYP11B2 (0.42) PARP1TNKSTNKS2CYP11B2PRMT5
SCHEMBL25035220 0.95 CYP11B2 (0.42) PARP1TNKSTNKS2CYP11B2PRMT5
SCHEMBL26642195 0.93 TLR9 (0.46) PRMT5CCNT1CCNA2CDK2CDK9
SCHEMBL30830495 0.88 GPR119 (0.47) CYP11B2PRMT5OPRD1OPRK1GPR119
SCHEMBL25935411 0.88 PARP1 (0.43) PARP1TNKSTNKS2TACR1CYP11B2
SCHEMBL30768744 0.87 USP2 (0.50) GPR119KITSCD5
SCHEMBL25819356 0.87 CYP11B2 (0.42) PARP1TNKSTNKS2CYP11B2PRMT5
SCHEMBL30830964 0.87 GPR119 (0.44) PARP1TNKSTNKS2TACR1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 WO disclosed